← Back to all trials
Recruiting
NCT06292845
Ex Vivo Tumor Visualization and Resection Margin Assessment Using Topically Applied Fluorescent Imaging Agents
Conditions: Solid Tumor, Adult
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 200
Sponsor: Erasmus Medical Center
Location: Erasmus University Medical Center Rotterdam South Holland
Summary
This is a proof-of-principle study, that uses freshly resected human solid tumor specimens to assess the performance of topically applied fluorescent imaging agents for the detection of tumor tissue and close / tumor-positive resection margins ex vivo. Surgery will be performed in conformity with hospital protocol. The study will not interfere with the standard clinical care.
Eligibility Criteria
Inclusion Criteria:
1. Patients with a biopsy-proven solid tumor, scheduled for surgery at the Erasmus Medical Center.
2. Signed and dated informed consent obtained before any study-related procedure is performed.
Exclusion Criteria:
1. Terminated surgical procedure.
2. No fresh specimen available.
3. Participation in a clinical trial for which the patient receives another fluorophore perioperatively.
Source: ClinicalTrials.gov (NCT06292845). StuddyBuddy aggregates publicly available trial information.
